MedTrace Logo

Patient Factors Associated With Fragmentation of Copper Intrauterine Device (IUD) Requiring Hysteroscopic Removal

NCT07351084 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2026-06-30

Study results available
· View outcomes & findings →

Summary

The purpose of this retrospective chart review was to identify risks factors for patients associated to Cooper IUD fragmentation upon removal resulting in the requirement of a hysteroscopy evaluation.

Conditions

  • Intrauterine Device Complications
  • Contraceptive Device Failure
  • IUD Fragmentation
  • Retained Intrauterine Device
  • Female Contraception
  • Women's Health
  • Reproductive Health

Sponsors & Collaborators

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Annabel Mancillas, MD MPH FACOG · University of Kansas Medical Center

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-28
Primary Completion
2025-06-26
Completion
2025-06-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07351084 on ClinicalTrials.gov